Androgen deprivation therapy in advanced prostate cancer: insights from a real-world patient survey on health-related quality of life and information and communication sources.
ADT
EPIC26
FACT
HRQoL
Healthcare communication
Patient organisation
Patient-reported outcomes
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257
Informations de publication
Date de publication:
19 Jun 2024
19 Jun 2024
Historique:
accepted:
05
06
2024
medline:
19
6
2024
pubmed:
19
6
2024
entrez:
19
6
2024
Statut:
aheadofprint
Résumé
Androgen deprivation therapy (ADT) is a cornerstone treatment for advanced and metastatic prostate cancer. Real-world and patient-reported insights into ADT's impact on health-related quality of life (HRQoL) and communication experiences in healthcare settings remain underexplored. This patient organisation-initiated online survey aimed to assess these aspects. Between December 2022 and August 2023, the patient organisation Think Blue Vlaanderen and the AZ Sint-Jan Hospital (Bruges, Belgium) invited ADT-treated patients to participate in a prospective, online, cross-sectional, patient-reported outcome survey. Demographic, clinical, HRQoL (FACT and EPIC-26), communication sources and information modality data were collected. Descriptive statistics and comparative analyses were applied. A total of 276/312 (88.5%) participating patients were on ADT at time of survey administration and completion, with the majority receiving a 3-monthly regimen. Sexual HRQoL was low and narrowly distributed (median (IQR): 16.7 (16.7-16.7)), with 84% of patients having erectile dysfunction (ED). Patients finding their ED problematic were more likely to seek pharmaceutical treatment. Hormonal HRQoL was widely distributed (median (IQR): 65 (45-85)), which improved with prolonged ADT duration. Physically active patients reported less lack of energy, but increased hot flashes. Within consistent FACT-G summary scores (median (IQR): 64.50 (54.75-77.00)), improved emotional wellbeing with prolonged ADT was noted. Multidisciplinary communication and multimodal information provision improved patient satisfaction. Patient organisation-initiated surveys offer real-world and patient-reported insights. Patient-tailored HRQoL assessments and longitudinal follow-up, physical activity, and multidisciplinary and multimodal communication approaches are warranted to improve patient-centred care in patients receiving ADT.
Identifiants
pubmed: 38896183
doi: 10.1007/s11136-024-03712-1
pii: 10.1007/s11136-024-03712-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
James, N. D., Tannock, I., N’Dow, J., Feng, F., Gillessen, S., Ali, S. A., Trujillo, B., Al-Lazikani, B., Attard, G., Bray, F., Compérat, E., Eeles, R., Fatiregun, O., Grist, E., Halabi, S., Haran, Á., Herchenhorn, D., Hofman, M. S., Jalloh, M., … Xie, L.-P. (2024). The Lancet Commission on prostate cancer: planning for the surge in cases. The Lancet, 403(10437), 1683–1722.
doi: 10.1016/S0140-6736(24)00651-2
Cornford, P., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A. M., van der Kwast, T. H., Lam, T. B., Lardas, M., Liew, M., Mason, M. D., Moris, L., … Mottet, N. (2021). EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: Treatment of relapsing and metastatic prostate cancer. European Urology, 79(2), 263–282. https://doi.org/10.1016/j.eururo.2020.09.046
doi: 10.1016/j.eururo.2020.09.046
Nguyen, P. L., Alibhai, S. M. H., Basaria, S., D’Amico, A. V., Kantoff, P. W., Keating, N. L., Penson, D. F., Rosario, D. J., Tombal, B., & Smith, M. R. (2015). Adverse effects of androgen deprivation therapy and strategies to mitigate them. European Urology, 67(5), 825–836. https://doi.org/10.1016/j.eururo.2014.07.010
doi: 10.1016/j.eururo.2014.07.010
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study. The Lancet Oncology, 7(11), 903–909. https://doi.org/10.1016/S1470-2045(06)70910-X
doi: 10.1016/S1470-2045(06)70910-X
Coens, C., Pe, M., Dueck, A. C., Sloan, J., Basch, E., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Devlin, N., Dorme, L., Flechtner, H.-H., Gotay, C., Griebsch, I., Groenvold, M., King, M., Kluetz, P. G., Koller, M., … Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium. (2020). International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. The Lancet Oncology, 21(2), e83–e96. https://doi.org/10.1016/S1470-2045(19)30790-9
doi: 10.1016/S1470-2045(19)30790-9
Di Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., Warrington, L., Zhang, L., Apostolidis, K., Freeman-Daily, J., Ripamonti, C. I., Santini, D., ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. (2022). The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline. Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO, 33(9), 878–892. https://doi.org/10.1016/j.annonc.2022.04.007
doi: 10.1016/j.annonc.2022.04.007
Bultijnck, R., Surcel, C., Ploussard, G., Briganti, A., De Visschere, P., Fütterer, J., Ghadjar, P., Giannarini, G., Isbarn, H., Massard, C., Sooriakumaran, P., Valerio, M., van den Bergh, R., & Ost, P. (2016). Practice patterns compared with evidence-based strategies for the management of androgen deprivation therapy-induced side effects in prostate cancer patients: Results of a European Web-based Survey. European Urology Focus, 2(5), 514–521. https://doi.org/10.1016/j.euf.2016.02.009
doi: 10.1016/j.euf.2016.02.009
Saesen, R., Van Hemelrijck, M., Bogaerts, J., Booth, C. M., Cornelissen, J. J., Dekker, A., Eisenhauer, E. A., Freitas, A., Gronchi, A., Hernán, M. A., Hulstaert, F., Ost, P., Szturz, P., Verkooijen, H. M., Weller, M., Wilson, R., Lacombe, D., & van der Graaf, W. T. (2023). Defining the role of real-world data in cancer clinical research: The position of the European organisation for research and treatment of cancer. European Journal of Cancer, 186, 52–61. https://doi.org/10.1016/j.ejca.2023.03.013
doi: 10.1016/j.ejca.2023.03.013
Szymanski, K. M., Wei, J. T., Dunn, R. L., & Sanda, M. G. (2010). Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology, 76(5), 1245–1250. https://doi.org/10.1016/j.urology.2010.01.027
doi: 10.1016/j.urology.2010.01.027
Sanda, M. G., Wei, J. T., & Litwin, M. S. (2002). Scoring instructions for the expanded prostate cancer index composite short form (EPIC-26). The University of Michigan. https://medicine.umich.edu/sites/default/files/content/downloads/Scoring%20Instructions%20for%20the%20EPIC%2026.pdf
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993). The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 11(3), 570–579. https://doi.org/10.1200/JCO.1993.11.3.570
doi: 10.1200/JCO.1993.11.3.570
FACIT.org. (n.d.). Functional assessment of cancer therapy - general. FACIT.org. https://www.facit.org/measures/fact-g
Van der Weijst, L., Machingura, A., Alanya, A., Lidington, E., Wac, K., Wintner L. M., Senna L. P. C., Bultijnck, R., Pe, M., on behalf of the EORTC Quality of Life Group. (2023, October 21). Improving completion rates of patient-reported outcome measures in cancer clinical trials: What are the recommendations? International Society for Quality of Life Research Annual Conference 2023, Calgary, Canada. https://www.eortc.org/blog/2023/09/22/eortc-quality-of-life-group-projects-to-be-presented-at-isoqol-2023/
Paterson, C., Kata, S. G., Nandwani, G., Das Chaudhury, D., & Nabi, G. (2017). Unmet supportive care needs of men with locally advanced and metastatic prostate cancer on hormonal treatment: A mixed methods study. Cancer Nursing, 40(6), 497–507. https://doi.org/10.1097/NCC.0000000000000482
doi: 10.1097/NCC.0000000000000482
Li, R., Wittmann, D., Nelson, C. J., Salter, C. A., Mulhall, J. P., Byrne, N., Nolasco, T. S., Ness, M., Gupta, N., Cassidy, C., Crisostomo-Wynne, T., & Loeb, S. (2022). Unmet sexual health needs of patients and female partners following diagnosis and treatment for prostate cancer. The Journal of Sexual Medicine, 19(12), 1797–1803. https://doi.org/10.1016/j.jsxm.2022.08.195
doi: 10.1016/j.jsxm.2022.08.195
Bond, C. B., Jensen, P. T., Groenvold, M., & Johnsen, A. T. (2019). Prevalence and possible predictors of sexual dysfunction and self-reported needs related to the sexual life of advanced cancer patients. Acta Oncologica, 58(5), 769–775. https://doi.org/10.1080/0284186X.2019.1566774
doi: 10.1080/0284186X.2019.1566774
Venderbos, L. D. F., Remmers, S., Deschamps, A., Dowling, J., Carl, E.-G., Azevedo, N., & Roobol, M. J. (2023). The Europa Uomo patient reported outcome study 2.0-prostate cancer patient-reported outcomes to support treatment decision-making. European Urology Focus, 9(6), 1024–1036.
doi: 10.1016/j.euf.2023.05.006
Gupta, N., Zebib, L., Wittmann, D., Nelson, C. J., Salter, C. A., Mulhall, J. P., Byrne, N., Nolasco, T. S., Schofield, E., & Loeb, S. (2023). Unmet sexual health resource needs and preferences for interventions to address these needs among female partners of patients with prostate cancer. Urology. https://doi.org/10.1016/j.urology.2023.12.007
doi: 10.1016/j.urology.2023.12.007
Edmunds, K., Tuffaha, H., Scuffham, P., Galvão, D. A., & Newton, R. U. (2020). The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: A rapid review. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 28(12), 5661–5671. https://doi.org/10.1007/s00520-020-05637-0
doi: 10.1007/s00520-020-05637-0
Grondhuis Palacios, L. A., Krouwel, E. M., den Oudsten, B. L., den Ouden, M. E. M., Kloens, G. J., van Duijn, G., Putter, H., Pelger, R. C. M., & Elzevier, H. W. (2018). Suitable sexual health care according to men with prostate cancer and their partners. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 26(12), 4169–4176. https://doi.org/10.1007/s00520-018-4290-2
doi: 10.1007/s00520-018-4290-2
Preiß, M., Friedrich, M., Stolzenburg, J.-U., Zenger, M., & Hinz, A. (2019). Response shift effects in the assessment of urologic cancer patients’ quality of life. European Journal of Cancer Care, 28(4), e13027. https://doi.org/10.1111/ecc.13027
doi: 10.1111/ecc.13027
Sharpe, L., Butow, P., Smith, C., McConnell, D., & Clarke, S. (2005). Changes in quality of life in patients with advanced cancer: Evidence of response shift and response restriction. Journal of Psychosomatic Research, 58(6), 497–504. https://doi.org/10.1016/j.jpsychores.2005.02.017
doi: 10.1016/j.jpsychores.2005.02.017
Dunn, J., Ralph, N., Green, A., Frydenberg, M., & Chambers, S. K. (2020). Contemporary consumer perspectives on prostate cancer survivorship: Fifty voices. Psycho-Oncology, 29(3), 557–563. https://doi.org/10.1002/pon.5306
doi: 10.1002/pon.5306
King, A. J. L., Evans, M., Moore, T. H. M., Paterson, C., Sharp, D., Persad, R., & Huntley, A. L. (2015). Prostate cancer and supportive care: A systematic review and qualitative synthesis of men’s experiences and unmet needs. European Journal of Cancer Care, 24(5), 618–634. https://doi.org/10.1111/ecc.12286
doi: 10.1111/ecc.12286
Cockle-Hearne, J., Charnay-Sonnek, F., Denis, L., Fairbanks, H. E., Kelly, D., Kav, S., Leonard, K., van Muilekom, E., Fernandez-Ortega, P., Jensen, B. T., & Faithfull, S. (2013). The impact of supportive nursing care on the needs of men with prostate cancer: A study across seven European countries. British Journal of Cancer, 109(8), 2121–2130. https://doi.org/10.1038/bjc.2013.568
doi: 10.1038/bjc.2013.568
Bergengren, O., Kaihola, H., Borgefeldt, A.-C., Johansson, E., Garmo, H., & Bill-Axelson, A. (2022). Satisfaction with Nurse-led follow-up in prostate cancer patients—a nationwide population-based study. European Urology Open Science, 38, 25–31. https://doi.org/10.1016/j.euros.2022.01.009
doi: 10.1016/j.euros.2022.01.009
Chambers, S. K., Hyde, M. K., Laurie, K., Legg, M., Frydenberg, M., Davis, I. D., Lowe, A., & Dunn, J. (2018). Experiences of Australian men diagnosed with advanced prostate cancer: A qualitative study. British Medical Journal Open, 8(2), e019917. https://doi.org/10.1136/bmjopen-2017-019917
doi: 10.1136/bmjopen-2017-019917
Quinten, C., Coens, C., Ghislain, I., Zikos, E., Sprangers, M. A. G., Ringash, J., Martinelli, F., Ediebah, D. E., Maringwa, J., Reeve, B. B., Greimel, E., King, M. T., Bjordal, K., Flechtner, H.-H., Schmucker-Von Koch, J., Taphoorn, M. J. B., Weis, J., Wildiers, H., Velikova, G., … EORTC Clinical Groups. (2015). The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation For Research And Treatment Of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. European Journal of Cancer, 51(18), 2808–2819. https://doi.org/10.1016/j.ejca.2015.08.027
doi: 10.1016/j.ejca.2015.08.027
Schmier, J. K., & Halpern, M. T. (2004). Patient recall and recall bias of health state and health status. Expert Review of Pharmacoeconomics & Outcomes Research, 4(2), 159–163. https://doi.org/10.1586/14737167.4.2.159
doi: 10.1586/14737167.4.2.159
Brown, A., Tan, A., Anable, L., Callander, E., De Abreu Lourenco, R., & Pain, T. (2022). Perceptions and recall of treatment for prostate cancer: A survey of two populations. Technical Innovations & Patient Support in Radiation Oncology, 24, 78–85. https://doi.org/10.1016/j.tipsro.2022.10.001
doi: 10.1016/j.tipsro.2022.10.001
Karazivan, P., Dumez, V., Flora, L., Pomey, M.-P., Del Grande, C., Ghadiri, D. P., Fernandez, N., Jouet, E., Las Vergnas, O., & Lebel, P. (2015). The patient-as-partner approach in health care: A conceptual framework for a necessary transition. Academic Medicine: Journal of the Association of American Medical Colleges, 90(4), 437–441. https://doi.org/10.1097/ACM.0000000000000603
doi: 10.1097/ACM.0000000000000603